Abiopharma

General Announcement: Monthly update pursuant to Catalist Rule 704(22)

General Announcement: Thomson Medical Group Launches Johor Bay Mega Project of Over MYR18 Billion GDV

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

Mandatory Cash Dividend/ Distribution:

Cash Dividend/ Distribution :: Mandatory

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Withdraw - Cash Dividend/ Distribution :: Mandatory

Withdraw - Cash Dividend/ Distribution :: Mandatory

Mandatory Cash Dividend/ Distribution:

Withdraw - Cash Dividend/ Distribution :: Mandatory

Withdraw - Cash Dividend/ Distribution :: Mandatory

Withdraw - Notice Of Record Date

Withdraw - Notice Of Record Date

General Announcement: ANNOUNCEMENT ON THE EVALUATION REPORT ON THE 2024 ACTION PLAN AND ON THE 2025 ACTION PLAN

FDA approve FENOFIBRATE